Cargando…

Genome-scale CRISPR screen reveals neddylation to contribute to cisplatin resistance of testicular germ cell tumours

BACKGROUND: Type II testicular germ cell tumours (TGCT) are the most prevalent tumours in young men. Patients suffering from cisplatin-resistant TGCTs are facing very poor prognosis demanding novel therapeutic options. Neddylation is a known posttranslational modification mediating many important bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Funke, Kai, Einsfelder, Ulf, Hansen, Aylin, Arévalo, Lena, Schneider, Simon, Nettersheim, Daniel, Stein, Valentin, Schorle, Hubert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241889/ https://www.ncbi.nlm.nih.gov/pubmed/37024667 http://dx.doi.org/10.1038/s41416-023-02247-5

Ejemplares similares

Transcriptional CDK Inhibitors as Potential Treatment Option for Testicular Germ Cell Tumors
por: Funke, Kai, et al.
Publicado: (2022)

Neddylation regulates excitatory synaptic transmission and plasticity
por: Brockmann, Marisa M., et al.
Publicado: (2019)

The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo
por: Jostes, Sina, et al.
Publicado: (2016)

The plasticity of germ cell cancers and its dependence on the cellular microenvironment
por: Nettersheim, Daniel, et al.
Publicado: (2017)

Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors
por: Nettersheim, Daniel, et al.
Publicado: (2018)

Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
por: Lobo, João, et al.
Publicado: (2020)

Brentuximab vedotin exerts profound antiproliferative and pro‐apoptotic efficacy in CD30‐positive as well as cocultured CD30‐negative germ cell tumour cell lines
por: Schönberger, Stefan, et al.
Publicado: (2017)

Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry
por: Fichtner, A., et al.
Publicado: (2022)

The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas
por: Nettersheim, Daniel, et al.
Publicado: (2016)

Imaging of testicular germ cell tumours
por: Dalal, P U, et al.
Publicado: (2006)

Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer
por: Nitzsche, B, et al.
Publicado: (2012)

Influence of Nodal signalling on pluripotency factor expression, tumour cell proliferation and cisplatin-sensitivity in testicular germ cell tumours
por: Harpelunde Poulsen, K., et al.
Publicado: (2020)

Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours
por: Mendoza, J, et al.
Publicado: (2013)

Recent advances in testicular germ cell tumours
por: Mele, Teresa, et al.
Publicado: (2021)

Testicular Germ Cell Tumours and Proprotein Convertases
por: Velado-Eguskiza, Aitziber, et al.
Publicado: (2022)

Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors
por: Bakardjieva-Mihaylova, Violeta, et al.
Publicado: (2019)

Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors
por: Singh, Ratnakar, et al.
Publicado: (2019)

Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells
por: Fung, M K L, et al.
Publicado: (2006)

Expression of BLIMP1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors
por: Eckert, Dawid, et al.
Publicado: (2008)

Testicular microlithiasis as a familial risk factor for testicular germ cell tumour
por: Coffey, J, et al.
Publicado: (2007)

Bone disease in testicular and extragonadal germ cell tumours.
por: Hitchins, R. N., et al.
Publicado: (1988)

Microsatellite instability in human testicular germ cell tumours.
por: Huddart, R. A., et al.
Publicado: (1995)

Glycolipids of human primary testicular germ cell tumours.
por: Olie, R. A., et al.
Publicado: (1996)

Clinical and genetic aspects of testicular germ cell tumours
por: Holzik, Martijn F Lutke, et al.
Publicado: (2008)

Cutaneous metastasis from testicular germ cell tumour
por: Joel, Anjana, et al.
Publicado: (2014)

Scrotal Involvement with Testicular Nonseminomatous Germ Cell Tumour
por: O'Leary, C. G., et al.
Publicado: (2016)

Testicular Germ Cell Tumours—The Role of Conventional Ultrasound
por: Belfield, Jane, et al.
Publicado: (2022)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment
por: Nettersheim, Daniel, et al.
Publicado: (2016)

Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines.
por: Burger, H., et al.
Publicado: (1998)

IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance
por: Selfe, Joanna, et al.
Publicado: (2018)

Novel sequential therapy with metformin enhances the effects of cisplatin in testicular germ cell tumours via YAP1 signalling
por: He, Kancheng, et al.
Publicado: (2022)

Targeting EpCAM by a Bispecific Trifunctional Antibody Exerts Profound Cytotoxic Efficacy in Germ Cell Tumor Cell Lines
por: Schönberger, Stefan, et al.
Publicado: (2020)

IGF signalling in germ cells and testicular germ cell tumours: roles and therapeutic approaches
por: Selfe, J., et al.
Publicado: (2019)

Analysis of TET Expression/Activity and 5mC Oxidation during Normal and Malignant Germ Cell Development
por: Nettersheim, Daniel, et al.
Publicado: (2013)

The role of surgery in metastatic testicular germ cell tumours (GCT).
por: Newlands, E. S., et al.
Publicado: (1989)

Somatic mutations of KIT in familial testicular germ cell tumours
por: Rapley, E A, et al.
Publicado: (2004)

Long-term sequelae of treatment for testicular germ cell tumours.
por: Bissett, D., et al.
Publicado: (1990)

Radiotherapy in testicular germ cell tumours – a literature review
por: Jonska-Gmyrek, Joanna, et al.
Publicado: (2017)

The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors
por: Timmerman, Dennis M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jehb5dblfmum3disi2v8apufb3